Reply

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We thank Chhablani and associates for their interest in our article and their comments, which mainly concern the methodology of our study. They expressed concern that some of our patients…

read more

Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After Laser In Situ Keratomileusis: A Prospective Randomized Clinical Trial

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After Laser In Situ Keratomileusis: A Prospective Randomized Clinical Trial

We perused with great interest the randomized controlled trial by Shojaei and associates, which studied the effect of timolol eye drops in refractive outcomes in eyes with myopic regression after…

read more

Reply

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Reply

I thank Lyons for his comments and for alluding to Marmor’s editorial, providing an opportunity to respond to both. His first concern is that the use of hydroxychloroquine not be…

read more

Impact of the Revised American Academy of Ophthalmology Guidelines Regarding Hydroxychloroquine Screening on Actual Practice

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Impact of the Revised American Academy of Ophthalmology Guidelines Regarding Hydroxychloroquine Screening on Actual Practice

This letter refers to the article “Impact of the Revised American Academy of Ophthalmology Guidelines Regarding Hydroxychloroquine Screening in Actual Practice,” by Browning, and to the accompanying editorial by Marmor….

read more

Reply

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We thank Galvis and associates for their interest in our article and their thoughtful comments. They suggested that the amount of change in corneal higher-order aberrations with age is less…

read more

Reply

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We appreciate the interest and comments by Dr Eggenberger in regard to our recent article examining the incidence of optic neuritis in patients using anti–tumor necrosis factor therapies. His letter…

read more

Interleukin 21, Interleukin 23, and Transforming Growth Factor β1 in HLA-A29-Associated Birdshot Retinochoroidopathy

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Interleukin 21, Interleukin 23, and Transforming Growth Factor β1 in HLA-A29-Associated Birdshot Retinochoroidopathy

Purpose To determine the peripheral levels of 20 immune mediators in serum samples from patients with birdshot retinochoroidopathy (BSRC). Design Single-center prospective case-control study. Methods The serum of 17 BSRC…

read more

Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study

Jan 9, 2017 by in OPHTHALMOLOGY Comments Off on Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study

I read with interest the article “Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study”; however, I have some hesitation…

read more
Get Clinical Tree app for offline access